These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18195722)

  • 1. Neuromodulation versus neurotoxin for the treatment of refractory detrusor overactivity: for neurotoxin.
    Smaldone MC; Chancellor MB
    Nat Clin Pract Urol; 2008 Mar; 5(3):120-1. PubMed ID: 18195722
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromodulation versus neurotoxin for the treatment of refractory detrusor overactivity: for neuromodulation.
    Nakib N; Siegel S
    Nat Clin Pract Urol; 2008 Mar; 5(3):118-9. PubMed ID: 18195723
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical application of Clostridium botulinum type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity.
    Lee JC; Yokoyama T; Hwang HJ; Arimitsu H; Yamamoto Y; Kawasaki M; Takigawa T; Takeshi K; Nishikawa A; Kumon H; Oguma K
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):201-11. PubMed ID: 17692094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.
    Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P
    J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A.
    Charrua A; Avelino A; Cruz F
    Handb Exp Pharmacol; 2011; (202):345-74. PubMed ID: 21290235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Botulinum toxin in urogynaecology.
    Sinha D; Karri K; Arunkalaivanan AS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):4-11. PubMed ID: 17275980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
    Schmid DM; Roy S; Sulser T; Scheiner D
    BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of sacral neuromodulation for detrusor overactivity.
    Vignes JR; Deloire M; Petry K
    Neurourol Urodyn; 2009; 28(1):8-12. PubMed ID: 18785181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin type A: the poison that can treat the sick.
    Novara G
    Eur Urol; 2009 Mar; 55(3):560-2. PubMed ID: 18805630
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.
    Drake MJ
    BJU Int; 2008 Jul; 102 Suppl 1():11-6. PubMed ID: 18665973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Haferkamp A
    Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromodulation versus medication for overactive bladder: the case for early intervention.
    Burks FN; Peters KM
    Curr Urol Rep; 2009 Sep; 10(5):342-6. PubMed ID: 19709480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
    Radziszewski P; Crayton R; Zaborski J; Członkowska A; Borkowski A; Bossowska A; Majewski M
    Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Fowler CJ
    Eur Urol; 2009 Mar; 55(3):712. PubMed ID: 18814958
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Schurch B
    Eur Urol; 2009 Mar; 55(3):711-2. PubMed ID: 18814956
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
    Sangster P; Kalsi V
    BJU Int; 2008 Jul; 102 Suppl 1():17-9. PubMed ID: 18665974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
    Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
    Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.